Millions of us just want to get back to some sort of normalcy. We’re all tired of the health crisis. We’re sick of the masks, the deaths, the shutdowns, and the fears. To be honest, most of us are just tired of hearing about it – day in, and day out. Sure, millions of vaccines are being distributed every day. However, infection rates are still rising. All thanks to new strains of the virus, states lifting restrictions, and signs of crisis fatigue. On top of that, millions of Americans say they won’t get the vaccine. At this point, there’s no telling when – or if life will get back to normal. What we do know is that along with vaccines, health officials agree that contact tracing is essential to control the situation. In fact, “It will remain the best tool for containing outbreaks among those who refuse, or are too young, to be vaccinated and could provide an early warning sign if new variants prove resistant to vaccines,” says Politico. That’s where a company like Contakt World Technologies (CSE:HELP)(OTC:TLOOF)(FWB:B21)– a digital contact tracing platform can help. Other top companies racing to help are Laboratory Corp. of America Holdings (NYSE:LH), Abbott Laboratories (NYSE:ABT), Quest Diagnostics (NYSE:DGX), Chembio Diagnostics (NASDAQ:CEMI).
Look at Contakt World Technologies (CSE:HELP)(OTC:TLOOF)(FWB:B21) for example
Contakt World Technologies announced its agreement in principle with Satcher Health Leadership Institute, Morehouse School of Medicine to help collect de-identified demographic data for the Health Equity Tracker Project through Smart Health RM and other products and services provided by Contakt World like Engagency. This updates the previously announced collaboration between Contakt World and SHLI now that Health Equity Tracker is operational.
Justin Beck, Chief Visionary Officer for Contakt World, said, "National health equity leader Daniel E. Dawes teaches us that you can't fix problems you don't understand via data. The systemic omission or destruction of racial and ethnic data in public health and healthcare systems mean that disparities often aren't addressed politically - sometimes by design."
He added, "We learned about this on Episode 2 of Contakt World: Truth in Healthon iHeartRadio entitled 'COVID The Great Revealer' in my exclusive interview with Daniel E. Dawes, and through Daniel's book published by Johns Hopkins University Press: The Political Determinants of Health. We learned about the oppression of data again, particularly among American Indian and Alaska Natives, speaking with Abigail Echo-Hawk, Chief Research Officer at Seattle Indian Health Board and Director of the Urban Indian Health Institute, on Episode 8 of Contakt World: Truth in Health entitled 'General Disparities? Or Data Genocide?'"
A long-term initiative of the leading institution Satcher Health Leadership Institute at Morehouse School of Medicine, Health Equity Tracker was designed to improve collection and transparency for key demographic data so we can address disparities in healthcare and ultimately improve outcomes for the most vulnerable among us who have suffered from 150+ years systemic inequities. HETP was designed through SHLI's Health Equity Task Force, which involved thought leadership from leaders all over the country in health equity, public health, healthcare, pandemic response, epidemiology, members of Congress in the United States, and Contakt World's co-founder and board member Robin Coleman, a publisher for Johns Hopkins University Press. Funding from Google.org, Gilead Sciences, Annie E. Casey Foundation, and CDC Foundation enabled the project in its formative stages.
"Since the launch of our Health Equity Task Force, Contakt World has been a critical partner in propelling actionable solutions and thought leadership into action," said Daniel E. Dawes. "Now that the HET is operational, Smart Health RM can help collect de-identified data from public health agencies and healthcare where gaps exist as a data partner for Health Equity Tracker. Engagency can also help to identify underserved populations and drive them to their local health department or provider, leveraging Contakt World's agency partnership with Unified Partnerships via iHeartMedia."
"Health agencies, organizations like National Association of County and City Health Officials, and public health professionals prioritize health equity in all they do. We hope our data partnership with HET continues to distinguish Contakt World, much like our innovation around communications and community engagement does," added CVO Beck.
"Since the launch of our Health Equity Task Force, Contakt World has been a critical partner in propelling actionable solutions and thought leadership into action," said Daniel E. Dawes. "Now that the HET is operational, Smart Health RM can help collect de-identified data from public health agencies and healthcare where gaps exist as a data partner for Health Equity Tracker. Engagency can also help to identify underserved populations and drive them to their local health department or provider, leveraging Contakt World's agency partnership with Unified Partnerships via iHeartMedia."
Other related developments from around the markets include:
Laboratory Corp. of America Holdings (NYSE:LH), a leading life sciences company, announced results for the second quarter ended June 30, 2021, and raised full-year guidance. “Our strategy focusing on science, innovation and technology led to strong second quarter results as we continued to advance health care and patient experiences,” said Labcorp Chairman and CEO Adam Schechter. “Patients and pharmaceutical clients accelerated their return to normal health care and business activities, which drove 46% revenue growth in our base business. In light of our second quarter performance and improved outlook, we are raising full-year financial guidance.”
Abbott Laboratories (NYSE:ABT), announced financial results for the second quarter ended June 30, 2021. Second-quarter sales of $10.2 billion increased 39.5 percent on a reported basis and 35.0 percent on an organic basis, which excludes the impact of foreign exchange. Second-quarter GAAP diluted EPS was $0.66 and adjusted diluted EPS, which excludes specified items, was $1.17, reflecting 105.3 percent growth versus the prior year. Abbott continues to project full-year 2021 diluted EPS from continuing operations on a GAAP basis of $2.75 to $2.95 and full-year adjusted diluted EPS from continuing operations of $4.30to $4.50, reflecting strong, double-digit growth versus the prior year.
Quest Diagnostics Inc. (NYSE:DGX), the world's leading provider of diagnostic information services, announced financial results for the second quarter ended June 30, 2021. "We had another strong quarter, with a faster than expected recovery in our base business," said Steve Rusckowski, Chairman, CEO and President. "This was the first quarter since 2019 that organic base testing revenues grew in the quarter, driven by contributions from new hospital lab management contracts as well as people returning to the healthcare system. We are well-positioned to continue our momentum and support the return to health care in the coming months, which is reflected in the outlook we have provided for the remainder of 2021."
Chembio Diagnostics Inc. (NASDAQ:CEMI), a leading point-of-care diagnostics company focused on infectious diseases, reported financial results for the quarter ended June 30, 2021. “In the second quarter, we focused on international commercial opportunities where our DPP COVID test has been approved. These efforts were successful, resulting in the largest order in company history for DPP SARS-CoV-2 Antigen tests from our longstanding customer Bio-Manguinhos. We also made progress on our clinical activity to support U.S. regulatory submissions for our DPP COVID-19 tests,” said Richard Eberly, Chembio’s President and Chief Executive Officer. “Looking forward, we believe the investments we have made in product development, expanding our commercial infrastructure and our automated manufacturing operations position us for future success. The recently raised capital has strengthened the balance sheet and will support execution of our strategic initiatives.”
Legal Disclaimer / Except for the historical information presented herein, matters discussed in this article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice.Contakt World Technologies has paid three thousand five hundred dollars for advertising and marketing services to be distributed by Winning Media. Winning Media is only compensated for its services in the form of cash-based compensation. Winning Media owns ZERO shares of Contakt World Technologies. Please click here for full disclaimer.
Contact Information:
2818047972
[email protected]
